Getting the Deal Through: Navigating Antitrust Scrutiny of Health System Deals and Beyond

Overview


According to a new report by the Health Care Cost Institute, nearly three-quarters of 112 metropolitan areas across 43 states have “highly concentrated” hospital markets—showing a rise of such areas from 67% in 2012 to 72% in 2016. And in today’s regulatory environment, this trend shows no sign of deceleration as health systems grapple with reimbursement, cost and other mission critical pressures.

This M&A activity is set against a backdrop of intensive antitrust scrutiny. The Federal Trade Commission (FTC) and often state attorneys general reviews can be challenging from a time and resource perspective. Join McDermott’s healthcare antitrust team for a webinar in which they’ll discuss and offer insight on what health systems and other industry participants can do to best position their deal for review. Topics include first-hand observations on various government practices, including:

  • Greater willingness to investigate discrete individual overlapping service lines and increasingly narrow geographic areas;
  • Growing reliance on econometric tools and economic analysis in their reviews;
  • Analytical approach toward markets where narrow and tiered networks are on the rise; and
  • Assessment of how local ACOs or CINs may factor into competitive effects analysis of a health system merger.

Time
12:00 – 1:00 pm ET

Webinar

Dig Deeper

London, United Kingdom / McDermott Event / June 17, 2021

2021 European Healthcare Services Private Equity Leadership Forum

Webinar / McDermott Event / January 26, 2021

Managed Care Spotlight: Recapping 2020 and Looking Ahead to 2021

Virtual Event Series / McDermott Event / January 21 – February 4, 2021

9th McDermott International Japan Seminar | Virtual Event Series

Virtual Event / Speaking Engagements / January 7 & 11-13, 2021

2021 J.P. Morgan Healthcare Conference